Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cancer Clinical Decision Tools Market In 2029?

The market size of cancer clinical decision utilities has experienced notable expansion in the past few years. This growth is expected to persist, with predictions indicating an increase from $0.5 billion in 2024 to $0.55 billion in 2025, replicating a compound annual growth rate (CAGR) of 9.5%. The previously observed progress can be credited to the escalating occurrences of cancer, heightened intricacy in cancer therapies, an amplified call for personalized treatments, increased adoption of value-focused healthcare, a larger availability of cancer-related data, and governmental backing for research and development pertaining to cancer.

What Growth Rate Is Forecasted for the Cancer Clinical Decision Tools Market by 2029?

The market size for cancer clinical decision tools is projected to witness robust growth in the coming years, expanding to $0.79 billion in 2029 with an annual compound growth rate of 9.8%. The anticipated growth within the forecasted period can be attributed to factors such as the global increase in aged population, patient involvement and consensus-based decision-making, patient-focused care, clinical studies and medicine rooted in evidence. Noteworthy trends during the forecast period encompass developments in medical imaging, AI-powered clinical decision assistance, telemedicine along with remote consultations, predictive analytics, consistency and norms related to data, as well as ethical and regulatory considerations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3463&type=smp

Which Key Companies Are Shaping the Future of the Cancer Clinical Decision Tools Market?

Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.

Which Factors Are Driving Demand in the Cancer Clinical Decision Tools Industry?

The global surge in cancer cases is projected to fuel the expansion of the cancer clinical decision tools market. As per the American Cancer Society’s January 2022 estimation, the US is expected to witness 1.9 million new cancer cases and approximately 609,360 cancer-related deaths, translating to around 1,670 fatalities daily. The four prevalent cancer types globally include lung, prostate, bowel, and female breast cancer, representing 43% of all fresh cancer cases. Therefore, the increasing global cancer prevalence rates will enhance the necessity for cancer clinical decision tools for quicker treatment decisions, thereby aiding the growth of the cancer clinical decision tools market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3463&type=smp

How Is the Cancer Clinical Decision Tools Market Segmented by Several Divisions?

The cancer clinical decision tools market covered in this report is segmented –

1) By Type: Risk Assessment Tool(RAT), Qcancer

2) By End-User: Hospital, Clinics

Subsegments:

1) By Risk Assessment Tool (RAT): Family History Assessment, Genetic Testing and Counseling, Lifestyle and Environmental Risk Factors Evaluation

2) By Qcancer: Symptom Checker, Risk Calculator, Guideline-Based Recommendations

What are the Emerging Market Trends Driving the Growth of the Cancer Clinical Decision Tools Industry?

Prominent businesses within the cancer clinical decision tools market are venturing into novel products like the BenchMark Ultra Plus tissue staining system to attain an edge over the competition. The BenchMark Ultra Plus system enhances tissue staining procedures, enabling quicker and precise pathology outcomes. For example, F. Hoffmann-La Roche AG, a healthcare firm based in Switzerland, introduced the BenchMark Ultra Plus tissue staining system in June 2022. This system offers heightened workflow productivity, improved testing protocols, and eco-friendly features. Moreover, it enables pathologists to provide top-notch, time-critical results to healthcare providers and patients. As an evolution in the BenchMark series, the BenchMark Ultra Plus system automates erstwhile manual slide-by-slide actions, precipitating a monumental shift in cancer diagnostics.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-clinical-decision-tool-global-market-report

Which Regions Are Driving Growth in the Cancer Clinical Decision Tools Market?

The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3463

This Report Delivers Insight On:

1. How big is the cancer clinical decision tools market, and how is it changing globally?

2. Who are the major companies in the cancer clinical decision tools market, and how are they performing?

3. What are the key opportunities and risks in the cancer clinical decision tools market right now?

4. Which products or customer segments are growing the most in the cancer clinical decision tools market?

5. What factors are helping or slowing down the growth of the cancer clinical decision tools market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model